Gasrric cancer
Conditions
Interventions
Sponsors
The Second Hospital of Shandong University
Eligibility
Sex/Gender
All
Age
30 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Gastric cancer group: (1) Aged 30 (inclusive) to 75 (inclusive) years, no gender limit; (2) The examination results in the last six months met the pathological diagnostic criteria for gastric cancer specified in this study. 2. Chronic atrophic gastritis group: (1) Aged between 40 (inclusive) and 70 (inclusive) years, no gender limit; (2) Previously diagnosed with chronic atrophic gastritis (clear pathology, possibly accompanied by intestinal metaplasia, excluding cancer). 3. Healthy people group: (1) Aged between 40 (inclusive) and 70 (inclusive) years, no gender limit; (2) No previous gastric disease (clear pathology), no abnormal manifestations of gastric mucosa.
Exclusion criteria
Exclusion criteria: 1. Gastric cancer group: (1) Subjects whose current Child-Pugh classification is C; (2) Subjects with liver cirrhosis due to other causes are suggested by previous examination results; (3) HIV-Ab+; (4) Active pulmonary tuberculosis has been diagnosed in the past; (5) Diagnosed with malignant tumors before admission or during hospitalization, including but not limited to gastric cancer; (6) Subjects who have received allogeneic blood transfusion or cell therapy within one year; (7) Pregnant subjects. 2. Chronic atrophic gastritis group: (1) Subjects with HCV, HDV, HEV, HIV infection at the same time; (2) Active pulmonary tuberculosis has been diagnosed in the past; (3) Diagnosed with malignant tumor before admission or during hospitalization, including but not limited to gastric cancer; (4) Subjects who have received allogeneic blood transfusion or cell therapy within 1 year; (5) Pregnant subjects; (6) Other unexplained gastric diseases. 3. Healthy people group: (1) Subjects with HCV, HDV, HEV, HIV infection at the same time; (2) Active pulmonary tuberculosis has been diagnosed in the past; (3) Diagnosed with malignant tumor before admission or during hospitalization, including but not limited to gastric cancer; (4) Subjects who have received allogeneic blood transfusion or cell therapy within 1 year; (5) Pregnant subjects; (6) Other unexplained liver diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival;Disease-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to progression; | — |
Countries
China
Contacts
Public ContactWang Chuanxin
The Second Hospital of Shandong University
Outcome results
None listed